Literature DB >> 15246109

Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.

Natalia V Kuznetsova1, Antonella Forlino, Wayne A Cabral, Joan C Marini, Sergey Leikin.   

Abstract

Here we report the structural and functional studies of collagen from the Brtl mouse, a heterozygous knock-in model for Osteogenesis Imperfecta, which has a G349C substitution introduced in one col1a1 allele. We observed that 25+/-5% of alpha 1(I) chains in different tissues and in different extracts from matrix deposited by cultured cells were S-S-linked mutant dimers. Apparently mutant and normal molecules are equally well incorporated into the matrix and they form mature covalent crosslinks with the same efficiency. We found different extents of post-translational overmodification of mutant molecules in different tissues, but we found no consistent differences between lethal and non-lethal animals. We did not detect any changes in the thermal stability or rate of thermal denaturation of mutant collagen. We also did not detect any changes in collagen-collagen recognition and interactions except for disruption of quasi-crystalline lateral packing of molecules in tendons from some, mostly prepubertal, mutant animals. In contrast, alpha 1(I)(3) collagen from the oim mouse--the only other non-lethal murine OI model studied by similar techniques--has altered stability, fibrillogenesis, collagen-collagen interactions and produces a more consistent and more pronounced disruption of tendon crystallinity. Nevertheless, while the G349C substitution causes moderate or lethal OI, heterozygous oim mice are much less affected. Overall, our results suggest that OI symptoms and phenotype variation in G349C animals are related to abnormal interactions of mutant collagen helices with other matrix molecules or abnormal function of osteoblasts rather than to abnormal structure, physical properties or interactions between mutant collagen helices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246109     DOI: 10.1016/j.matbio.2004.03.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  12 in total

1.  The role of apoptosis in mineralizing murine versus avian micromass culture systems.

Authors:  Rani Roy; Valery Kudryashov; Itzhak Binderman; Adele L Boskey
Journal:  J Cell Biochem       Date:  2010-10-15       Impact factor: 4.429

2.  Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta.

Authors:  Joseph M Wallace; Bradford G Orr; Joan C Marini; Mark M Banaszak Holl
Journal:  J Struct Biol       Date:  2010-08-07       Impact factor: 2.867

3.  Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease.

Authors:  Shu-Wei Chang; Sandra J Shefelbine; Markus J Buehler
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

Review 4.  Collagen misfolding mutations: the contribution of the unfolded protein response to the molecular pathology.

Authors:  John F Bateman; Matthew D Shoulders; Shireen R Lamandé
Journal:  Connect Tissue Res       Date:  2022-02-26       Impact factor: 3.417

5.  Arsenic-induced decreases in the vascular matrix.

Authors:  Allison M Hays; R Clark Lantz; Laurel S Rodgers; James J Sollome; Richard R Vaillancourt; Angeline S Andrew; Joshua W Hamilton; Todd D Camenisch
Journal:  Toxicol Pathol       Date:  2008-09-23       Impact factor: 1.902

6.  In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta.

Authors:  Cristina Panaroni; Roberta Gioia; Anna Lupi; Roberta Besio; Steven A Goldstein; Jaclynn Kreider; Sergey Leikin; Juan Carlos Vera; Edward L Mertz; Egon Perilli; Fabio Baruffaldi; Isabella Villa; Aurora Farina; Marco Casasco; Giuseppe Cetta; Antonio Rossi; Annalisa Frattini; Joan C Marini; Paolo Vezzoni; Antonella Forlino
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

Review 7.  Animal models of osteogenesis imperfecta and related syndromes.

Authors:  Agnès S Kamoun-Goldrat; Martine F Le Merrer
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

8.  Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.

Authors:  Ethan Daley; Elizabeth A Streeten; John D Sorkin; Natalia Kuznetsova; Sue A Shapses; Stephanie M Carleton; Alan R Shuldiner; Joan C Marini; Charlotte L Phillips; Steven A Goldstein; Sergey Leikin; Daniel J McBride
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

9.  Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues.

Authors:  Erica P Homan; Caressa Lietman; Ingo Grafe; Jennifer Lennington; Roy Morello; Dobrawa Napierala; Ming-Ming Jiang; Elda M Munivez; Brian Dawson; Terry K Bertin; Yuqing Chen; Rhonald Lua; Olivier Lichtarge; John Hicks; Mary Ann Weis; David Eyre; Brendan H L Lee
Journal:  PLoS Genet       Date:  2014-01-23       Impact factor: 5.917

10.  Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta.

Authors:  Laura Bianchi; Assunta Gagliardi; Silvia Maruelli; Roberta Besio; Claudia Landi; Roberta Gioia; Kenneth M Kozloff; Basma M Khoury; Paul J Coucke; Sofie Symoens; Joan C Marini; Antonio Rossi; Luca Bini; Antonella Forlino
Journal:  Hum Mol Genet       Date:  2015-08-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.